Results 251 to 260 of about 143,948 (293)

Hydroxycitric acid inhibits ferroptosis and ameliorates benign prostatic hyperplasia by upregulating the Nrf2/GPX4 pathway. [PDF]

World J Urol
Yang D, Zhai C, Ren J, Bai J, Li T, Lu M, Tang Y, Wei L, Luo R, Tong F.   +9 more
europepmc   +1 more source

Prostate Artery Embolization (PAE) in the Treatment of Benign Prostatic Hyperplasia: A Case Series and Narrative Review. [PDF]

J Clin Med
Iossa V, Punzi E, Pandolfo SD, Spena G, Russo P, Giulioni C, Aveta A, Spirito L, Lombardi G, Imperatore V.   +9 more
europepmc   +1 more source

Effectiveness and safety of doxazosin in hypertensive patients with benign prostatic hyperplasia

, 2000
E Becerril
openalex   +1 more source

Benign Prostatic Hyperplasia.

Primary Care, 2019
Robert Langan
semanticscholar   +1 more source

Identification of novel plasma proteins as potential therapeutic targets for benign prostatic hyperplasia: a proteome-wide association study. [PDF]

Transl Androl Urol
Luo X, Wu C, Xiong Y, Wang W, Jiang Q, Liu Z.   +5 more
europepmc   +1 more source

Evaluation of serum alpha-1B glycoprotein and C-reactive protein levels as biomarkers of canine benign prostatic hyperplasia. [PDF]

Vet World
Wongbandue G, Ploypetch S, Pruksakitcharoen P, Udomrit K, Nujan K, Seekhumtae R, Thubthim T, Prapaiwan N.   +7 more
europepmc   +1 more source

Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health. [PDF]

Curr Urol Rep
Singh D, Nguyen T, Burnam P, Greenberg J, Raheem O, Hellstrom W.   +5 more
europepmc   +1 more source

Transurethral holmium laser enucleation of prostate shows remarkable efficacy in treating benign prostatic hyperplasia. [PDF]

Am J Transl Res
He FR, Jian GD, Tan RZ, Xu YN, Zheng B.
europepmc   +1 more source

A Comprehensive Review of the Clinical Evidence on the Efficacy, Effectiveness, and Safety of Silodosin for the Treatment of Benign Prostatic Hyperplasia. [PDF]

Cureus
Akhtar OS, Singh V, Bhojani KA, Dharmadhikari S, Bhargave C, Mane A, Mehta S.   +6 more
europepmc   +1 more source

Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants. [PDF]

Front Oncol
Tang C, Guo X, Zou Q, Wang X, Sheng J, Shen D, Sun C, Li S, Shen R.   +8 more
europepmc   +1 more source